McGrane Nicholas 4
4 · Evolent Health, Inc. · Filed Feb 5, 2018
Insider Transaction Report
Form 4
McGrane Nicholas
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2018-02-01+22,401→ 53,990 total - Award
Class A Common Stock Option (right to buy)
2018-02-01+52,609→ 52,609 totalExercise: $13.95Exp: 2028-02-01→ Class A Common Stock (52,609 underlying)
Footnotes (4)
- [F1]Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 25% annually beginning February 1, 2019.
- [F3]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F4]Securities vest at a rate of 25% annually beginning February 1, 2019.